Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
08/2003
08/14/2003US20030153801 Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
08/14/2003US20030153764 Process for preparing 4-substituted piperidines
08/14/2003US20030153751 Inhibitors of phospholipase enzymes
08/14/2003US20030153604 Anticoagulants
08/14/2003US20030153602 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
08/14/2003US20030153597 Therapeutic treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease, nervous system disorders and cardiovascular disorders
08/14/2003US20030153580 Cis-imidazolines
08/14/2003US20030153577 Cyclic amine derivatives-CCR-3 receptor antagonists
08/14/2003US20030153560 Fused n-heterocylic derivatives; mitogen-activated protein kinase inhibitors
08/14/2003US20030153557 Treating osteoporosis, cardiovascular disorders, restenosis, arteriosclerosis, nephropathies or retinopathies; antitumor and antiinflammatory agents
08/14/2003US20030153555 Novel compounds
08/14/2003US20030153553 Quinoline derivatives
08/14/2003US20030153507 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
08/14/2003US20030153004 Learning enhancement, cognition activators, sleep disorders, psychological disorders; screening Dna which codes serotonin receptor
08/14/2003CA2478423A1 Gamma secretase inhibitors
08/14/2003CA2475637A1 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003CA2475336A1 Novel tetrazole derivative useful as herbicides
08/14/2003CA2475320A1 Quinoxalinones and their use especially in the treatment of cardiovascular diseases
08/14/2003CA2474508A1 Ansamycins having improved pharmacological and biological properties
08/14/2003CA2474168A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003CA2473181A1 Quinoline derivatives as npy antagonists
08/13/2003EP1334974A1 Cyclic disulfide compound, process of producing the same and optical product comprising the same
08/13/2003EP1334101A2 Tridentate ligands and relative complexes with transition metals
08/13/2003EP1334100A1 Bombesin receptor antagonists
08/13/2003EP1334098A2 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
08/13/2003EP1334097A2 Process for the preparation of ligands for olefin polymerization catalysts
08/13/2003EP1334094A1 Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles
08/13/2003EP1334085A1 Sulfamides as gamma-secretase inhibitors
08/13/2003EP1333829A1 Treatment of sexual dysfunction using bombesin antagonists
08/13/2003EP1333827A2 Estrogen receptor modulators
08/13/2003EP1333824A2 Treatment of sexual dysfunction
08/13/2003EP1216244B1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as D4 antagonists
08/13/2003EP1075470B1 Novel analgesic and immunomodulatory cannabinoids
08/13/2003EP1019411A4 Process for synthesizing carbapenem side chain intermediates
08/13/2003EP0976745B1 4-tetrahydropyridylpyrimidine derivatives
08/13/2003EP0946539B1 Sulphonamide derivatives, process for their preparation, and their use as medicaments
08/13/2003EP0927179B1 Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase
08/13/2003EP0879233B1 Chinoline and benzimidazole derivatives as bradykinin agonists
08/13/2003CN1436186A Process for preparation of sulfonamide derivs. and crystals thereof
08/13/2003CN1436185A Thrombin receptor antagonists
08/13/2003CN1436184A Substd. pyridine herbicides
08/13/2003CN1436179A Oxadiazole derivs. having anticancer effects
08/13/2003CN1436172A 1,2-dihydropyridine compounds, process for preparation of same and use thereof
08/13/2003CN1117744C 1-(1,2-disubstd. piperidinyl)-4-substd. piperazine derivs.
08/13/2003CN1117569C Bicyclic fibrinogen antagonists
08/12/2003US6605730 3-(2-Thienyl)-5-phenyl-1H-pyrazole compounds of given formula
08/12/2003US6605725 Treating a central or peripheral nervous system disorder or condition through modulation of a voltage-dependent potassium channel
08/12/2003US6605707 Process for the preparation of 6-O-propargyl erythromycin derivatives
08/12/2003US6605677 Olefin polymerization processes using supported catalysts
08/12/2003US6605637 Lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
08/12/2003US6605634 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
08/12/2003US6605633 Such as 5-Bromo-2-phenyl-1H-indole-3-butanoic acid
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605631 Ortho-substituted 2-methoxyiminophenyl-N-methylacetamides
08/12/2003US6605626 Antithrombotic agents
08/12/2003US6605618 Antidiabetic agents; hypoglycemic agents; anticholesterol agents; side effect reduction
08/12/2003US6605617 Treating a patient in need of an inhibitor of vascular endothelial growth factor receptor tyrosine kinase
08/12/2003US6605615 Administering to a patient suffering from hypercholesterolemia, hyperlipedimea and other metabolic disorders an effective amount of hydrozone, oxime or imine derivatives
08/12/2003US6605608 Amino acid derivatives and drugs containing the same as the active ingredient
08/12/2003US6605607 Antihypertensives; hyperprolactinaemia related conditions; certain central nervous system disorders
08/12/2003US6605604 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
08/12/2003CA2277473C Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
08/07/2003WO2003064414A1 Tricyclic compounds useful as angiotensin ii agonists
08/07/2003WO2003064411A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
08/07/2003WO2003064397A1 Indazole compounds useful as protein kinase inhibitors
08/07/2003WO2003064376A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps)
08/07/2003WO2003063872A1 Non-sedating barbituric acid derivatives
08/07/2003WO2003063797A2 Cycloalkyl inhibitors of potassium channel function
08/07/2003WO2003063794A2 2,4-pyrimidinediamine compounds and their uses
08/07/2003WO2003063771A2 N4-acylcytosine nucleosides for treatment of viral iinfections
08/07/2003WO2003030886A3 Allylamides useful in the treatment of alzheimer's disease
08/07/2003WO2003010361A3 Nitrogen atom transfer
08/07/2003WO2002002593A3 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
08/07/2003US20030149269 Substituted piperidine derivatives
08/07/2003US20030149266 Administering to a patient (a warm blooded animal, such as man) an effective amount of a pyrimidine derivative for treating cancer, cell proliferation, and inhibition of focal adhesion kinase effect
08/07/2003US20030149089 Antibacterial compounds
08/07/2003US20030149086 EP4 receptor selective agonists in the treatment of osteoporosis
08/07/2003US20030149081 For therapy and prophylaxis of asthma, seasonal and perennial allergic rhinitis, sinusitus, conjunctivitis, food allergy, scombroid poisoning, psoriasis, urticaria, pruritus, eczema, inflammatory bowel disease, atherosclerosis
08/07/2003US20030149079 Novel benzofuran derivatives
08/07/2003US20030149057 Anti-cancer compounds
08/07/2003US20030149043 N-[(substituted five-membered di-or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
08/07/2003US20030149030 7-phenyl-benzo [b] thiophen amide derivatives
08/07/2003US20030149029 Administering to a mammal indole derivative compound for therapy of asthma
08/07/2003US20030149025 Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis
08/07/2003US20030149023 Novel compounds with analgesic effect
08/07/2003US20030149020 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system
08/07/2003US20030149019 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system
08/07/2003US20030149018 1-aryl- or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
08/07/2003US20030148890 Organic compounds
08/07/2003CA2474451A1 Cycloalkyl inhibitors of potassium channel function
08/07/2003CA2474277A1 2,4-pyrimidinediamine compounds and their uses
08/06/2003EP1332135A1 Tagging compounds and process for use in aida libraries
08/06/2003EP1332133A1 Metabotropic glutamate receptor antagonists
08/06/2003EP1332132A2 Enamine derivatives as cell adhesion molecules
08/06/2003EP1332131A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP0946538B1 Indane or dihydroindole derivatives
08/06/2003EP0821674B1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
08/06/2003EP0804419B1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
08/06/2003CN1434818A Novel compounds
08/06/2003CN1434816A Novel compounds